These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1822317)

  • 21. Milacemide: a placebo-controlled study in senile dementia of the Alzheimer type.
    Dysken MW; Mendels J; LeWitt P; Reisberg B; Pomara N; Wood J; Skare S; Fakouhi JD; Herting RL
    J Am Geriatr Soc; 1992 May; 40(5):503-6. PubMed ID: 1634705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la Tetrahydroaminoacridine.
    Chatellier G; Lacomblez L
    BMJ; 1990 Feb; 300(6723):495-9. PubMed ID: 2107926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sustained efficacy and safety of idebenone in the treatment of Alzheimer's disease: update on a 2-year double-blind multicentre study.
    Gutzmann H; Hadler D
    J Neural Transm Suppl; 1998; 54():301-10. PubMed ID: 9850939
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of xantinolnicotinate in patients with dementia.
    Kanowski S; Fischhof PK; Grobe-Einsler R; Wagner G; Litschauer G
    Pharmacopsychiatry; 1990 May; 23(3):118-24. PubMed ID: 2197635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of major depression on clinical and psychometric assessment of senile dementia of the Alzheimer type.
    Rubin EH; Kinscherf DA; Grant EA; Storandt M
    Am J Psychiatry; 1991 Sep; 148(9):1164-71. PubMed ID: 1882993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind, randomized, placebo-controlled pilot study with anapsos in senile dementia: effects on cognition, brain bioelectrical activity and cerebral hemodynamics.
    Alvarez XA; Pichel V; Pérez P; Laredo M; Corzo D; Zas R; Fernández-Novoa L; Sempere JM; Díaz J; Cacabelos R
    Methods Find Exp Clin Pharmacol; 2000 Sep; 22(7):585-94. PubMed ID: 11196347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional, cognitive and behavioral effects of donepezil in patients with moderate Alzheimer's disease.
    Gauthier S; Feldman H; Hecker J; Vellas B; Emir B; Subbiah P;
    Curr Med Res Opin; 2002; 18(6):347-54. PubMed ID: 12442882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of hormone therapy on depressive symptoms and cognitive functions in women with Alzheimer disease: a 12 month randomized, double-blind, placebo-controlled study of low-dose estradiol and norethisterone.
    Valen-Sendstad A; Engedal K; Stray-Pedersen B; ; Strobel C; Barnett L; Meyer N; Nurminemi M
    Am J Geriatr Psychiatry; 2010 Jan; 18(1):11-20. PubMed ID: 20094015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Piracetam plus lecithin trials in senile dementia of the Alzheimer type.
    Samorajski T; Vroulis GA; Smith RC
    Ann N Y Acad Sci; 1985; 444():478-81. PubMed ID: 3893273
    [No Abstract]   [Full Text] [Related]  

  • 30. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
    Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
    Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing therapeutic efficacy in a progressive disease: a study of donepezil in Alzheimer's disease.
    Johannsen P; Salmon E; Hampel H; Xu Y; Richardson S; Qvitzau S; Schindler R;
    CNS Drugs; 2006; 20(4):311-25. PubMed ID: 16599649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD).
    Nave S; Doody RS; Boada M; Grimmer T; Savola JM; Delmar P; Pauly-Evers M; Nikolcheva T; Czech C; Borroni E; Ricci B; Dukart J; Mannino M; Carey T; Moran E; Gilaberte I; Muelhardt NM; Gerlach I; Santarelli L; Ostrowitzki S; Fontoura P
    J Alzheimers Dis; 2017; 58(4):1217-1228. PubMed ID: 28550255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical efficacy of aniracetam, either as monotherapy or combined with cholinesterase inhibitors, in patients with cognitive impairment: a comparative open study.
    Koliaki CC; Messini C; Tsolaki M
    CNS Neurosci Ther; 2012 Apr; 18(4):302-12. PubMed ID: 22070796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Donepezil for vascular cognitive impairment.
    Malouf R; Birks J
    Cochrane Database Syst Rev; 2004; (1):CD004395. PubMed ID: 14974068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial.
    Kanowski S; Hoerr R
    Pharmacopsychiatry; 2003 Nov; 36(6):297-303. PubMed ID: 14663654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic efficacy of pyritinol in patients with senile dementia of the Alzheimer type (SDAT) and multi-infarct dementia (MID).
    Fischhof PK; Saletu B; Rüther E; Litschauer G; Möslinger-Gehmayr R; Herrmann WM
    Neuropsychobiology; 1992; 26(1-2):65-70. PubMed ID: 1475039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.
    Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Lyons B; Grossman F
    J Clin Psychiatry; 2003 Feb; 64(2):134-43. PubMed ID: 12633121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and tolerability of the γ-secretase inhibitor avagacestat in a phase 2 study of mild to moderate Alzheimer disease.
    Coric V; van Dyck CH; Salloway S; Andreasen N; Brody M; Richter RW; Soininen H; Thein S; Shiovitz T; Pilcher G; Colby S; Rollin L; Dockens R; Pachai C; Portelius E; Andreasson U; Blennow K; Soares H; Albright C; Feldman HH; Berman RM
    Arch Neurol; 2012 Nov; 69(11):1430-40. PubMed ID: 22892585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Naftidrofuryl in the treatment of mild senile dementia. A double-blind study.
    Grossmann WM; Standl A; May U; van Laak HH; Hirche H
    Pharmacopsychiatry; 1990 Nov; 23(6):265-73. PubMed ID: 2284328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An open-label extension trial of galantamine in patients with probable vascular dementia and mixed dementia.
    Erkinjuntti T; Kurz A; Small GW; Bullock R; Lilienfeld S; Damaraju CV;
    Clin Ther; 2003 Jun; 25(6):1765-82. PubMed ID: 12860497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.